DCM
CMD

Delpha Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Delpha Capital Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-111
Closed -$11K – 1473
2017
Q4 		$11K Buy
+111
New +$11.1K 0.01% 1048

Other funds holding CMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Delpha Capital Management's CMD Position: Q1 2018 in Review

Delpha Capital Management sold out of Cantel Medical Corporation (CMD) in Q1 2018, closing a stake of 111 shares — an estimated $11K sold.

Delpha Capital Management first reported a position in CMD in Q4 2017 and held it in 1 quarter. The position peaked at $11K in Q4 2017. 270 funds tracked by Wall St. Rank hold CMD as of Q1 2018.

  • Delpha Capital Management reported no remaining Cantel Medical Corporation position as of Q1 2018 after selling out during the quarter.
  • Delpha Capital Management sold 111 Cantel Medical Corporation shares in Q1 2018, an estimated $11K.
  • Delpha Capital Management first reported a position in Cantel Medical Corporation in Q4 2017 and held it in 1 quarter.
  • Delpha Capital Management's Cantel Medical Corporation position peaked at $11K in Q4 2017.
  • 270 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.